NCT00591253 Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00585208 Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance Status TERMINATED Phase PHASE3
NCT00552760 Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder Status COMPLETED Phase PHASE4
NCT00532558 Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT00532311 Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT00525772 Effect of Ciclesonide on Exercise Induced Bronchoconstriction Status COMPLETED Phase PHASE3
NCT00523367 COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI Status TERMINATED Phase NA
NCT00521820 Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure Status TERMINATED Phase PHASE3
NCT00521742 Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease Status COMPLETED Phase PHASE3
NCT00507546 Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia Status COMPLETED Phase PHASE4
NCT00494312 Safety Study of Pioglitazone Compared To Glyburide on Liver Function Status COMPLETED Phase PHASE4
NCT00492232 Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia Status COMPLETED Phase PHASE4
NCT00492011 Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers Status COMPLETED Phase PHASE4
NCT00487994 Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia Status COMPLETED Phase PHASE3
NCT00479986 Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease Status COMPLETED Phase PHASE4
NCT00471094 Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis Status COMPLETED Phase PHASE2